---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-023553"
form_type: "8-K"
ticker: "ROIV"
cik: "0001635088"
company_name: "Roivant Sciences Ltd."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T19:24:23.776554+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Roivant Sciences authorizes $500M share repurchase program

## Summary
- New $500M buyback authorization effective June 24, 2025, in addition to prior $1.5B program now exhausted.
- Program has no expiration date; funded from available cash and cash equivalents.
- Repurchases may be executed via open market, tender offers, or 10b5-1 trading plans.
- Timing and size depend on market price, business conditions, and other investment opportunities.
- The program may be suspended or discontinued at any time at the company's discretion.

## SEC filing metadata
- accession: 0001140361-25-023553
- form_type: 8-K
- ticker: ROIV
- cik: 0001635088
- company_name: Roivant Sciences Ltd.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635088/000114036125023553/0001140361-25-023553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635088/000114036125023553/ef20051006_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-023553
- JSON: https://secwatch.observer/filing/0001140361-25-023553.json
- Plain text: https://secwatch.observer/filing/0001140361-25-023553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.